
VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma
Scandinavian Biopharma has obtained a global license for VaxAlta Inc.’s intellectual property for the development of a new Campylobacter jejuni vaccine for humans. C. jejuni is one of the most common causes of bacterial diarrheal illness in humans. Common sources of C. jejuni include raw or undercooked poultry, raw milk, […]